Elliott, M. D., Vena, N., Marasa, M., Cocchi, E., Bheda, S., Bogyo, K., Shang, N., Zanoni, F., Verbitsky, M., Wang, C., Kolupaeva, V., Jin, G., Sofer, M., Gras Pena, R., Canetta, P. A., Bomback, A. S., Guay-Woodford, L. M., Hou, J., Gillespie, B. W., … Gharavi, A. G. (2024). Increased risk of kidney failure in patients with genetic kidney disorders. Journal of Clinical Investigation, 134(17). https://doi.org/10.1172/jci178573

Duret, L. C., Hamidouche, T., Steers, N. J., Pons, C., Soubeiran, N., Buret, D., Gilson, E., Gharavi, A. G., D’Agati, V. D., & Shkreli, M. (2024). Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy. Kidney International, 105(5), 980–996. https://doi.org/10.1016/j.kint.2024.02.009

Heerspink, H. J. L., Inker, L. A., Tighiouart, H., Collier, W. H., Haaland, B., Luo, J., Appel, G. B., Chan, T. M., Estacio, R. O., Fervenza, F., Floege, J., Imai, E., Jafar, T. H., Lewis, J. B., Kam-Tao Li, P., Locatelli, F., Maes, B. D., Perna, A., … Perrone, R. D. (2023). Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD. Journal of the American Society of Nephrology, 34(6), 955–968. https://doi.org/10.1681/asn.0000000000000117

Nasr, S. H., Kudose, S., Javaugue, V., Harel, S., Said, S. M., Pascal, V., Stokes, M. B., Vrana, J. A., Dasari, S., Theis, J. D., Osuchukwu, G. A., Sathick, I. J., Das, A., Kashkouli, A., Suchin, E. J., Liss, Y., Suldan, Z., Verine, J., Arnulf, B., … D’Agati, V. D. (2023). Pathological characteristics of light chain crystalline podocytopathy. Kidney International, 103(3), 616–626. https://doi.org/10.1016/j.kint.2022.11.026

Collier, W., Inker, L. A., Haaland, B., Appel, G. B., Badve, S. V., Caravaca-Fontán, F., Chalmers, J., Floege, J., Goicoechea, M., Imai, E., Jafar, T. H., Lewis, J. B., Li, P. K. T., Locatelli, F., Maes, B. D., Neuen, B. L., Perrone, R. D., Remuzzi, G., … Schena, F. P. (2023). Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD. Clinical Journal of the American Society of Nephrology, 18(2), 183–192. https://doi.org/10.2215/cjn.0000000000000050

Chen, Z., Matsumura, M., Mintz, G. S., Noguchi, M., Fujimura, T., Usui, E., Seike, F., Hu, X., Jin, G., Li, C., Salem, H., Fall, K. N., Shlofmitz, E., Kirtane, A. J., Cao, J. J., Moses, J. W., Ali, Z. A., Jeremias, A., Shlofmitz, R. A., & Maehara, A. (2022). Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis. Circulation: Cardiovascular Interventions, 15(9). https://doi.org/10.1161/circinterventions.121.011693

Javaugue, V., Valeri, A. M., Jaffer Sathick, I., Said, S. M., Erdogan Damgard, S., Murray, D. L., Klobucher, T., Andeen, N. K., Sethi, S., Fervenza, F. C., Leung, N., & Nasr, S. H. (2022). The characteristics of seronegative and seropositive non-hepatitis-associated cryoglobulinemic glomerulonephritis. Kidney International, 102(2), 382–394. https://doi.org/10.1016/j.kint.2022.03.030

Lomax-Browne, H. J., Medjeral-Thomas, N. R., Barbour, S. J., Gisby, J., Han, H., Bomback, A. S., Fervenza, F. C., Cairns, T. H., Szydlo, R., Tan, S.-J., Marks, S. D., Waters, A. M., Appel, G. B., D’Agati, V. D., Sethi, S., Nast, C. C., Bajema, I., Alpers, C. E., Fogo, A. B., … Pickering, M. C. (2022). Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis. Clinical Journal of the American Society of Nephrology, 17(7), 994–1007. https://doi.org/10.2215/cjn.16801221